Enovix (NASDAQ:ENVX) Stock Falls 16.7% – Should You Sell?

Enovix Corporation (NASDAQ:ENVX)’s share price was down 16.7% on Thursday. The stock traded as low as $2.33 and last traded at $2.3240. Approximately 2,350,579 shares were traded during trading, a decline of 67% from the average session volume of 7,067,294 shares. The stock had previously closed at $2.79.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Craig Hallum set a $7.00 price target on Enovix in a research report on Thursday, August 13th. William Blair cut shares of Enovix from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $25.00 price objective on shares of Enovix in a research note on Thursday, August 13th. B. Riley Financial lowered their target price on Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday, August 13th. Finally, TD Cowen upgraded shares of Enovix to a “hold” rating in a research report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.77.

Enovix Stock Down 15.0%

The stock has a market capitalization of $520.32 million, a P/E ratio of -2.93 and a beta of 2.34. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The stock’s fifty day moving average is $2.93 and its two-hundred day moving average is $5.09.

Enovix shares are set to split before the market opens on Friday, November 13th. The 5-4 split was recently announced. The newly minted shares will be distributed to shareholders after the closing bell on Thursday, November 12th.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02. The company had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The firm’s revenue was up 20.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, research analysts predict that Enovix Corporation will post -0.79 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Enovix

Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in Enovix in the 2nd quarter valued at approximately $100,054,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Enovix during the second quarter worth $8,689,000. Bank of America Corp DE bought a new position in shares of Enovix in the second quarter worth about $8,356,000. Bank of New York Mellon Corp bought a new position in Enovix in the 2nd quarter worth approximately $3,551,000. Finally, Deutsche Bank AG bought a new position in Enovix in the second quarter valued at about $3,343,000. 50.92% of the stock is owned by institutional investors and hedge funds.

About Enovix

Enovix Corporation is a battery technology company that develops lithium-ion batteries using a silicon-anode architecture. Its approach is designed to increase energy density while maintaining safety and cycle-life characteristics through a three-dimensional cell design and a mechanical constraint system that helps manage silicon expansion during charging.

The company’s products are intended for applications that require compact, high-performance power sources, including consumer electronics, wearable devices, Internet of Things equipment, industrial products, and defense and aerospace systems.